Researchers and physicians at the Temple Heart & Vascular Institute are international leaders in the development of new therapies and technologies to treat heart disease and related conditions. Their work spans the basic science laboratories of the Lewis Katz School of Medicine at Temple University to the operating rooms at Temple University Hospital.
Laboratory investigation into the cellular and molecular mechanisms of heart disease takes place in several Temple research centers. Here, scientists focus on the biology of the heart, opening doors for more effective and targeted treatments—from novel pharmaceuticals and biologicals to therapies with genes, RNA interference, stem cells, and medical devices.
In addition to basic research, the Temple Heart & Vascular Institute is also a hub of clinical trials that are testing the effectiveness of new medications, innovative surgical techniques and the latest medical devices. The Institute’s robust clinical trials program means Temple patients often have access to new therapies and devices that are not commonly available at most hospitals.